Pharmaceuticals and biotechnology businesses are key end-customers, leveraging cancer biomarkers in the event of latest medications and therapies. This section significantly impacts the cancer biomarkers market demand, owing to usage in scientific trials and therapeutic focusing on, leading to more personalized and productive cancer treatment plans